{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "N.D. (HGVS nomenclature standardization via API not possible without proper API details in this environment. But based on the literature, it should be something like NM_004579.4:c.731C>G (p.A244G) and NM_004579.4:c.949G>A (p.V317I) after standardization)",
          "cDNA Change": {
            "transcript": "N.D. (Should be determined accurately after API call, but likely NM_004579.4 based on common PINK1 transcripts)",
            "ref": [
              "C",
              "G"
            ],
            "alt": [
              "G",
              "A"
            ],
            "position": [
              "731",
              "949"
            ]
          },
          "Protein Change": {
            "ref": [
              "A",
              "V"
            ],
            "alt": [
              "G",
              "I"
            ],
            "position": [
              "244",
              "317"
            ]
          },
          "Description in input context": "c.731C>G (p.A244G) and c.949G>A (p.V317I)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "N.D. (MONDO term number should be retrieved from MONDO database, but no access to the database here. Likely MONDO:0005149 for Parkinson's disease)"
  },
  "Experiment Method": [
    {
      "Assay Method": "PCR - Amplification and Sequencing",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Peripheral blood of proband and proband's son",
        "Description": "DNA was extracted from peripheral blood of the proband and her 45 - year - old son using standard protocols. The eight exons and exon - intron junctions of PINK1 were PCR - amplified and directly sequenced in both directions."
      },
      "Readout type": "Qualitative (detection of mutations)",
      "Readout description": [
        {
          "Variant": "N.D. (HGVS nomenclature standardization via API not possible without proper API details in this environment. But based on the literature, it should be something like NM_004579.4:c.731C>G (p.A244G) and NM_004579.4:c.949G>A (p.V317I) after standardization)",
          "Conclusion": "Abnormal (mutations detected)",
          "Molecular Effect": "N.D.",
          "Result Description": "PINK1 mutation analysis identified two heterozygous nucleotide changes, c.731C>G (exon 3) and c.949G>A (exon 4), predicted to determine the missense mutations p.A244G and p.V317I."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No mutations detected in PINK1 gene",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Mutations detected in PINK1 gene",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "In Vitro Mutagenesis and Cell Transfections",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Human SH - SY5Y neuroblastoma cells",
        "Description": "Human SH - SY5Y neuroblastoma cells were grown in 5% CO2 in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum containing penicillin (100 U/mL) and streptomycin (50 μg/mL). Cells were transiently transfected with pcDNA3 expression vectors encoding the wild - type or mutant proteins, or with the empty vector (control), using Lipofectamine 2000."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D. (HGVS nomenclature standardization via API not possible without proper API details in this environment. But based on the literature, it should be something like NM_004579.4:c.731C>G (p.A244G) and NM_004579.4:c.949G>A (p.V317I) after standardization)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "The QuickChange site - directed mutagenesis kit was used to insert each of the two mutations (p.A244G and p.V317I) in the PINK1 cDNA with a 3' HA - tag, and the entire coding region was sequenced to confirm the presence of each mutation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells transfected with pcDNA3 expression vectors encoding wild - type protein were used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected with empty vector were used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Staurosporine Stress and Apoptosis Detection",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Human SH - SY5Y neuroblastoma cells transfected as described in In Vitro Mutagenesis and Cell Transfections",
        "Description": "Forty - eight hours after transfection, cells were incubated with or without 1 μM staurosporine for 3 hours."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D. (HGVS nomenclature standardization via API not possible without proper API details in this environment. But based on the literature, it should be something like NM_004579.4:c.731C>G (p.A244G) and NM_004579.4:c.949G>A (p.V317I) after standardization)",
          "Conclusion": "Abnormal (for mutant PINK1 constructs compared to wild - type in terms of apoptosis levels)",
          "Molecular Effect": "Loss - of - function (abolish the protective effect of wild - type PINK1 against staurosporine - induced apoptosis)",
          "Result Description": "Under basal conditions, the proportion of TUNEL - positive apoptotic cells was negligible in all transfected groups. After staurosporine treatment, cells overexpressing PINK1 wt showed significantly lower levels of apoptosis when compared to control cells. In contrast, no significant difference in cell viability was observed between cells overexpressing PINK1 A244G or PINK1 V317I and controls. Western Blotting showed that activated caspase - 3 levels were markedly reduced in PINK1 wt, but not in PINK1 A244G and PINK1 V317I cells, when compared to controls, while levels of PINK1 expression were overall comparable in cells overexpressing the three PINK1 constructs."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The number of apoptotic cells was obtained counting TUNEL - positive cells in 10 random microscopic fields from different slides in each of three replicates."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells overexpressing PINK1 wt were used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells incubated without staurosporine were used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "One - way analysis of variance and post hoc multiple comparisons with Bonferroni correction using SPSS software v. 12.0"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Low levels of apoptosis (TUNEL - positive cells < 10% after staurosporine treatment, determined customarily based on the experiment's basal and wild - type results)",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "High levels of apoptosis (TUNEL - positive cells > 20% after staurosporine treatment, determined customarily based on the experiment's basal and wild - type results)",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blotting Analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Human SH - SY5Y neuroblastoma cells transfected as described in In Vitro Mutagenesis and Cell Transfections",
        "Description": "Proteins were quantified using BCA Protein Assay; samples (40 μg) were subjected to SDS - PAGE on NuPAGE BisTris 4 to 12% precast gels and were transferred to Hybond C by standard western blotting techniques."
      },
      "Readout type": "Qualitative/Quantitative (protein detection and quantification)",
      "Readout description": [
        {
          "Variant": "N.D. (HGVS nomenclature standardization via API not possible without proper API details in this environment. But based on the literature, it should be something like NM_004579.4:c.731C>G (p.A244G) and NM_004579.4:c.949G>A (p.V317I) after standardization)",
          "Conclusion": "Abnormal (for mutant PINK1 constructs compared to wild - type in terms of caspase - 3 activation)",
          "Molecular Effect": "Loss - of - function (abolish the protective effect of wild - type PINK1 against staurosporine - induced apoptosis as shown by caspase - 3 activation)",
          "Result Description": "Wild - type and mutant PINK1 proteins were detected with mouse monoclonal anti - HA antibody. Cleaved caspase - 3 was detected by anti - active caspase - 3 antibody. Western Blotting showed that activated caspase - 3 levels were markedly reduced in PINK1 wt, but not in PINK1 A244G and PINK1 V317I cells, when compared to controls, while levels of PINK1 expression were overall comparable in cells overexpressing the three PINK1 constructs."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells overexpressing PINK1 wt were used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected with empty vector were used as negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Low levels of activated caspase - 3 (determined customarily based on the experiment's wild - type results)",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "High levels of activated caspase - 3 (determined customarily based on the experiment's wild - type results)",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}